Anne E. Lykkesfeldt

Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant

Thomas Frogne, Rikke Vicki Benjaminsen, Katrine Sonne‐Hansen et al. · Breast Cancer Research and Treatment · 2008 · 155 citations · Full text

Medicine, Molecular Biology, Oncology +11

FOXM1 is a transcriptional target of ERα and has a critical role in breast cancer endocrine sensitivity and resistance

Julie Millour, Demetra Constantinidou, Alexandra Stavropoulou et al. · Oncogene · 2010 · 154 citations · Full text

Medicine, Bioinformatics, Oncology +12

Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial

Birgitte Rasmussen, Meredith M. Regan, Anne E. Lykkesfeldt et al. · The Lancet Oncology · 2007 · 151 citations

Medicine, Gynecology, Oncology +17

Classifications within Molecular Subtypes Enables Identification of BRCA1/BRCA2 Mutation Carriers by RNA Tumor Profiling

Martin J. Larsen, Torben A. Kruse, Qihua Tan et al. · PLoS ONE · 2013 · 117 citations · Full text

Life Sciences, Genetics, Oncology +17

Effect ofmts1 (S100A4) expression on the progression of human breast cancer cells

Mariam Grigorian, Noona Ambartsumian, Anne E. Lykkesfeldt et al. · International Journal of Cancer · 1996 · 107 citations

Medicine, Molecular Biology, Oncology +17